SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+0.97%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$435M
AUM Growth
+$435M
Cap. Flow
-$37M
Cap. Flow %
-8.52%
Top 10 Hldgs %
95.72%
Holding
17
New
Increased
2
Reduced
3
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$106M 24.45% 12,850,000
ABBV icon
2
AbbVie
ABBV
$372B
$106M 24.43% 1,580,000
DGX icon
3
Quest Diagnostics
DGX
$20.3B
$41.7M 9.6% 575,000 -200,000 -26% -$14.5M
MDCO
4
DELISTED
Medicines Co
MDCO
$39M 8.97% 1,361,900 +146,800 +12% +$4.2M
AEGR
5
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$38.6M 8.89% 2,036,829 +399,374 +24% +$7.58M
AMGN icon
6
Amgen
AMGN
$155B
$30.7M 7.07% 200,000 -118,000 -37% -$18.1M
MRK icon
7
Merck
MRK
$210B
$22.8M 5.24% 400,000
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11.5M 2.65% 360,000
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$11.2M 2.57% 6,524,505
RPRX
10
DELISTED
Repros Therapeutics Inc.
RPRX
$8.1M 1.86% 1,132,367
VVUS
11
DELISTED
Vivus Inc
VVUS
$6.08M 1.4% 2,573,943
KIN
12
DELISTED
Kindred Biosciences, Inc.
KIN
$4.7M 1.08% 689,091
AVEO
13
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$4.03M 0.93% 2,313,759 -257,000 -10% -$447K
ANIP icon
14
ANI Pharmaceuticals
ANIP
$2.03B
$1.92M 0.44% 31,000
GYRE icon
15
Gyre Therapeutics
GYRE
$703M
$1.76M 0.4% 630,000
CARM icon
16
Carisma Therapeutics
CARM
$8.98M
$116K 0.03% 41,200
AVDL
17
Avadel Pharmaceuticals
AVDL
$1.43B
-875,000 Closed -$15.7M